MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM
$24.6M
This Quarter Return
+3.08%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$159M
AUM Growth
+$159M
(-0.84%)
Cap. Flow
-$417K
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Y-mAbs Therapeutics
YMAB
|
$417K |
Sector Composition
| 1 | Healthcare | 85.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Royalty Pharma
RPRX
$15.6B
| $107M | 67.12% | 2,680,644 | – | – |
|
2
VanEck Gold Miners ETF
GDX
$19B
| $23.7M | 14.86% | 738,500 | – | – |
|
3
Caribou Biosciences
CRBU
$174M
| $10.2M | 6.39% | 674,196 | – | – |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $8.85M | 5.56% | 602,272 | – | – |
|
5
Illumina
ILMN
$15.8B
| $6.54M | 4.11% | 17,196 | – | – |
|
|
6
Y-mAbs Therapeutics
YMAB
$388M
| $3.1M | 1.95% | 191,176 -25,740 | -12% | -$417K |
|